FDA Health Claims Draft Guidance Should Value Totality Of Evidence – CRN
This article was originally published in The Tan Sheet
Executive Summary
FDA's apparent contention that results from randomized controlled trials invalidate conflicting information from observational studies on the effects of nutrients reflects "an intrinsic bias" within the agency or "a lack of fundamental understanding of research methods," according to the Council for Responsible Nutrition
You may also be interested in...
Need For Better Research Grows With Supplements' Popularity – NCCIH
Continued research on non-vitamin and -mineral products' safety is necessary, says National Center for Complementary and Integrative Health Director Josephine Briggs, and improved studies on their effects on users' health are a scientific priority in the center's strategic plan.
NCCAM Strategy Stresses Steps Toward Better Trials For Supplements
The nutritional product industry expects benefits from the National Center for Complementary and Alternative Medicine draft strategic plan's emphasis on funding more preliminary research needed to launch informative clinical trials on supplement ingredients
NCCAM Strategy Stresses Steps Toward Better Trials For Supplements
The nutritional product industry expects benefits from the National Center for Complementary and Alternative Medicine draft strategic plan's emphasis on funding more preliminary research needed to launch informative clinical trials on supplement ingredients